BIOSYSEN(01355): Jiln zbn hu wnrn wi dl fnghu gwn BIOSYSEN(01355): Kalin Capital appointed as independent financial advisor
The announcement of the Biological Systems Engineering (01355) was released, approved by the independent directors committee. Jialin Capital Limited, a licensed corporation that is regulated under the Securities and Futures Ordinance for Type 6 (advising on corporate finance), has been appointed as the independent financial advisor to provide advice to the independent directors committee and independent shareholders on subscription and settlement agreements and proposed transactions (including granting special approval).
BIOSYSEN (01355) announced that, with the approval of the Independent Directors Committee, Jalin Capital Limited, a licensed corporation under the Securities and Futures Ordinance to carry on regulated activities of Type 6 (advising on corporate finance), has been appointed as independent financial advisor to provide advice to the Independent Directors Committee and independent shareholders on the subscription and settlement agreement and the proposed transactions (including granting of special mandate) to be carried out thereunder.
Related Articles
KNOWLEDGE ATLAS (02513): It is recommended to issue A shares and list on the Sci-Tech Innovation Board.
On June 1st, SAMSONITE(01910) spent 21.6857 million Hong Kong dollars to repurchase 1.4754 million shares.
US Stock Market Move | IBM (IBM.US) rose more than 8% in early trading, with a cumulative increase of 40% since May.
KNOWLEDGE ATLAS (02513): It is recommended to issue A shares and list on the Sci-Tech Innovation Board.
On June 1st, SAMSONITE(01910) spent 21.6857 million Hong Kong dollars to repurchase 1.4754 million shares.
US Stock Market Move | IBM (IBM.US) rose more than 8% in early trading, with a cumulative increase of 40% since May.
